biotech news today glp-1 The race may have a new contender. π Regeneron reported Phase 3 data showing its obesity drug candidate delivered up to 19.3% weight loss at 48 weeks, approaching the efficacy seen GLP-1s and the Unintended Consequences
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5
























